CA
BPTH

Crewe Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Crewe Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$26 – 723
2023
Q3 		$26 Hold
4
– – ﹤0.01% 579
2023
Q2 		$125 Hold
4
– – ﹤0.01% 830
2023
Q1 		$98 Hold
4
– – ﹤0.01% 805
2022
Q4 		$106 Hold
4
– – ﹤0.01% 1010
2022
Q3 		$0 Hold
4
– – ﹤0.01% 1291
2022
Q2 		$0 Hold
4
– – ﹤0.01% 1168
2022
Q1 		$0 Hold
4
– – ﹤0.01% 509
2021
Q4 		$0 Hold
4
– – ﹤0.01% 474
2021
Q3 		$0 Hold
4
– – ﹤0.01% 479
2021
Q2 		$0 Buy
+4
New +$493 ﹤0.01% 495
2018
Q3 		– Hold
0
– – – 274
2018
Q2 		– Hold
0
– – – 287
2018
Q1 		– Hold
0
– – – 296
2017
Q4 		– Hold
0
– – – 276

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crewe Advisors's BPTH Position: Q4 2023 in Review

Crewe Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q4 2023, closing a stake of 4 shares — an estimated $26 sold.

Crewe Advisors first reported a position in BPTH in Q2 2021 and held it in 10 quarters. The position peaked at $125 in Q2 2023. 19 funds tracked by Wall St. Rank hold BPTH as of Q4 2023.

  • Crewe Advisors reported no remaining Bio-Path Holdings Inc position as of Q4 2023 after selling out during the quarter.
  • Crewe Advisors sold 4 Bio-Path Holdings Inc shares in Q4 2023, an estimated $26.
  • Crewe Advisors first reported a position in Bio-Path Holdings Inc in Q2 2021 and held it in 10 quarters.
  • Crewe Advisors's Bio-Path Holdings Inc position peaked at $125 in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2023.

Based on Crewe Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.